NuVision Biotherapies raised €1.2M in a funding round in Mar 2023. The company is based in Nottingham, UK. Investors in the round: MEIF Proof of Concept & Early Stage Fund, Mercia’s EIS Funds, Midlands Engine Investment Fund and 2 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
